Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
InspireMD, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $3.1 million, net income $11.8 million or $0.14 per basic and diluted share.
- Period
- the fourth quarter ended December 31, 2025
- Revenue
- $3.1 million
- Net income
- $11.8 million or $0.14 per basic and diluted share
- Result
- reported results
Exact text from the filing
of stroke, today announced financial and operating results for the fourth quarter and year ended December 31, 2025. Recent Business Highlights : ● Generated revenue of $3.1 million in the fourth quarter of 2025, up 62% year-over-year. ● Sustained strong commercial traction in the U.S. with the launch of CGuard Prime and continued growth in international
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
InspireMD, Inc. reported the year ended December 31, 2025 results: revenue $9.0 million, net income $48.8 million or $0.76 per basic and diluted share. Guidance initiated.
- Period
- the year ended December 31, 2025
- Revenue
- $9.0 million
- Net income
- $48.8 million or $0.76 per basic and diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
$9.2 million or $0.19 per basic and diluted share, for the same period in 2024. Financial Results for the Year Ended December 31, 2025 For the full year 2025, total revenue was $9.0 million, representing an increase of 28%, as compared to $7.0 million during the full year 2024. U.S. revenue for the full year 2025 was $1.4 million, representing the first two quarters
View on SEC.gov